HOME > ARCHIVE
ARCHIVE
- BUSINESS NEWS IN BRIEF
July 14, 2003
- BULLETIN
July 14, 2003
- CORPORATE ROUNDUP NEWS IN BRIEF
July 14, 2003
- Gatiflo Makes Dainippon Revise Mid-term Plan: President Miyatake
July 14, 2003
- 415 GEs, 145 Ingredients Added to NHI Price List
July 14, 2003
- FY2003 Basic Policy on Fiscal, Structural Reform Announced
July 14, 2003
- WORLD NEWS IN BRIEF
July 14, 2003
- Regulatory Reform Council Chairman Satisfied with FY2003 Basic Policy
July 14, 2003
- Mevalotin Retains Top Position, Followed by Gaster, Blopress: Survey
July 14, 2003
- Korosho Council Listens to Industry's Views on Action Plan
July 14, 2003
- Eisai to Beef Up Business Infrastructure in China
July 14, 2003
- 6 Drugs, Recommended for Approval in July
July 14, 2003
- Taisho Drops 7 of 11 Compounds from Bioventures
July 14, 2003
- CTD Applications Become Obligatory on July 1
July 14, 2003
- Sumitomo to Boost R&D Investment, Build Overseas Marketing Systems
July 14, 2003
- Total Fertility, Natural Increase in Population at Record Lows
July 14, 2003
- Daiichi Suntory Pharma to See Steady Growth After FY2007
July 14, 2003
- REGULATORY NEWS IN BRIEF
July 14, 2003
- Asahi Kasei Reinforces GE Line-up in Major Fields
July 14, 2003
- Aeon Welcia Stores Breaks Off Relations with Drug Eleven
July 14, 2003
ページ
I recently sat down with one of the leading medical directors in Japan to discuss the critical evolution of the medical science liaison (MSL) role.The MSL has transformed from a scientific resource into a strategic partner essential for successful product…
